Oppenheimer Remains a Buy on Nurix Therapeutics (NRIX)
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
According to TipRanks, Biegler is an analyst with an average return of -12.1% and a 31.68% success rate. Biegler covers the Healthcare sector, focusing on stocks such as Gilead Sciences, Regeneron, and Nurix Therapeutics.
In addition to Oppenheimer, Nurix Therapeutics also received a Buy from Truist Financial's Srikripa Devarakonda in a report issued on June 13. However, on June 3, Leerink Partners reiterated a Hold rating on Nurix Therapeutics (NASDAQ: NRIX).
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
36 minutes ago
- Yahoo
Don't Buy the Dips Blindly, Warns John Stotzfus
John Stoltzfus, chief investment strategist at Oppenheimer, discusses how clients view the recent market selloff and calls this a "very interesting time" for intermediate and long-term investors. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Bloomberg
an hour ago
- Bloomberg
Don't Buy the Dips Blindly, Warns John Stotzfus
John Stoltzfus, chief investment strategist at Oppenheimer, discusses how clients view the recent market selloff and calls this a 'very interesting time' for intermediate and long-term investors. (Source: Bloomberg)
Business Insider
4 hours ago
- Business Insider
President Trump Has Bought More Than $100 Million of Bonds This Year
U.S. President Donald Trump has bought more than $100 million worth of bonds since returning to the White House in January of this year. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The U.S. Office of Government Ethics has released a new report that shows President Trump made 690 transactions in financial markets since returning to power at the start of this year. The transactions include buying bonds, or debt, issued by local governments and U.S. corporations. In all, it appears that President Trump has personally bought bonds totaling more than $100 million. By law, the U.S. president must disclose 'reportable transactions' to the Office of Government Ethics. There are efforts within the U.S. Congress to prevent elected officials from transacting in the stock and bond market, which critics say amounts to self-dealing among politicians. Lots of Bonds The latest disclosure reveals that President Trump has bought bonds sold by a wide variety of entities, including U.S. municipal governments, as well as gas and water utilities, hospitals, and school boards. The president has also bought debt issued by a number of public companies, including T-Mobile (TMUS), UnitedHealth Group (UNH), and Home Depot (HD). President Trump also recently bought debt issued by technology giant Meta Platforms (META) worth as much as $500,000. Companies and governments issue bonds to raise capital to carry out projects, fuel their growth, refinance existing debt, and secure their financial stability. Investors who purchase the bonds, such as President Trump, receive interest payments over a set period of time. Vanguard Total Bond Market ETF Let's take a look at demand for U.S. bonds through a popular exchange-traded fund (ETF) that tracks the debt market. As one can see in the chart below, the Vanguard Total Bond Market ETF (BND) has risen 4% so far in 2025.
